Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-02 09:53 am Sale | 2023-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 0 0.000% | -420,710 (Position Closed) | Filing History |
| 2023-04-14 4:01 pm Purchase | 2023-04-04 | 13D | Cocrystal Pharma, Inc. COCP | FROST PHILLIP MD | 1,332,608 13.100% | 1,332,608 (New Position) | Filing History |
| 2023-04-12 4:09 pm Purchase | 2023-04-04 | 13G | Cocrystal Pharma, Inc. COCP | Hassan Fred | 1,015,229 10.000% | 1,015,229 (New Position) | Filing History |
| 2023-01-10 11:40 am Sale | 2022-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 420,710 11.000% | -57,467 (-12.02%) | Filing History |
| 2022-02-10 3:49 pm Sale | 2021-12-31 | 13G | Cocrystal Pharma, Inc. COCP | RENAISSANCE TECHNOLOGIES LLC | 158,577 1.950% | -170,588 (-51.82%) | Filing History |
| 2022-01-03 9:47 pm Sale | 2021-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 478,177 11.000% | -333,490 (-41.09%) | Filing History |
| 2021-06-09 5:44 pm Purchase | 2021-06-09 | 13D | Cocrystal Pharma, Inc. COCP | FROST PHILLIP MD | 310,526 3.800% | 310,526 (New Position) | Filing History |
| 2021-05-25 1:15 pm Unchanged | 2021-05-05 | 13D | Cocrystal Pharma, Inc. COCP | FiveT Investment Management Ltd | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-05-17 5:13 pm Purchase | 2021-05-05 | 13G | Cocrystal Pharma, Inc. COCP | Ayrton Capital LLC | 543,333 6.690% | 543,333 (New Position) | Filing History |
| 2021-05-12 2:13 pm Purchase | 2021-05-05 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 811,667 11.000% | 811,667 (New Position) | Filing History |
| 2021-02-16 09:46 am Sale | 2020-12-31 | 13G | Cocrystal Pharma, Inc. COCP | CVI Investments, Inc. | 0 0.000% | -288,462 (Position Closed) | Filing History |
| 2021-02-10 10:12 am Purchase | 2020-05-29 | 13G | Cocrystal Pharma, Inc. COCP | RENAISSANCE TECHNOLOGIES LLC | 329,165 5.760% | 329,165 (New Position) | Filing History |
| 2021-01-05 09:26 am Sale | 2020-12-31 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 0 0.000% | -288,462 (Position Closed) | Filing History |
| 2020-11-19 4:01 pm Purchase | 2020-11-13 | 13D | Cocrystal Pharma, Inc. COCP | OPKO HEALTH INC. OPK | 307,921 5.400% | 781 (+0.25%) | Filing History |
| 2020-03-10 4:10 pm Purchase | 2020-02-28 | 13D | Cocrystal Pharma, Inc. COCP | OPKO HEALTH INC. OPK | 307,140 7.800% | 260 (+0.08%) | Filing History |
| 2020-03-06 09:25 am Purchase | 2020-02-27 | 13G | Cocrystal Pharma, Inc. COCP | CVI Investments, Inc. | 288,462 7.300% | 288,462 (New Position) | Filing History |
| 2020-03-03 1:14 pm Sale | 2020-03-03 | 13G | Cocrystal Pharma, Inc. COCP | WASATCH ADVISORS LP | 0 0.000% | -149,958 (Position Closed) | Filing History |
| 2020-02-28 4:32 pm Sale | 2020-02-24 | 13G | Cocrystal Pharma, Inc. COCP | LSP Advisory B.V. | 136,086 4.200% | -75,035 (-35.54%) | Filing History |
| 2020-02-27 11:57 am Purchase | 2020-02-27 | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 288,462 11.000% | 288,462 (New Position) | Filing History |
| 2020-02-10 4:31 pm Purchase | 2019-12-31 | 13G | Cocrystal Pharma, Inc. COCP | LSP Advisory B.V. | 211,122 7.200% | 54,005 (+34.37%) | Filing History |